Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer
Limeng Wu, Wenjie Liu, Wenjie Liu, Yaoguang Huang, Chengze Zhu, Qun Ma, Qiong Wu, Liting Tian, Xiangling Feng, Mingyue Liu, Nan Wang, Xiangbo Xu, Xin Liu, Chang Xu, Jingsong Qiu, Zihua Xu, Wenwu Liu, Wenwu Liu, Qingchun Zhao
Topics & Concepts
TacrineChemistryCyclin-dependent kinase 2PharmacologyAcetylcholinesteraseToxicityIC50In vivoCell cycleApoptosisCholinesteraseBiochemistryIn vitroEnzymeBiologyOrganic chemistryBiotechnologyAdvanced Breast Cancer TherapiesMicrotubule and mitosis dynamicsCancer therapeutics and mechanisms